BCL3 and Autoimmunity: Specifically, developing comprehensive and comparative genome‐wide binding maps for Bcl‐3, IκBNS, and IκBζ in the same cell type, using Cut&Run or Cut&Tag technologies would be an invaluable resource to uncover the function of atypical IκBs, especially in lymphocytes and in the setting of autoimmunity and autoinflammatory diseases.